| Acute coronary syndrome |
| Prevalence Clinical features Differential diagnosis Investigations Therapy Prevention Prognosis |
With ECG changes or elevated cardiac enzymes There is no clear benefit from using lamifiban a Why?
|
Expiry date: June 2003
Levels
of Evidence used in grading these guides
| Authors | CM Ball , N Shenker |
| Reviewer | I K Jang |
| CAT Writers | N Shenker , CJ Wotton , CM Ball , RS Phillips |